OUR CAPABILITIES
Publications
See all our relevant publications below.
2023
Modhiran N, Lauer SM, Amarilla AA, et al. 2023. A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants. iScience.
Deliyannis G, Gherardin NA, Wong CY, et al. 2023. Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine. EBioMedicine.
2022
Panagides N, Zacchi LF, Souza MJ, et al. 2022. Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies. International Journal of Molecular Sciences.
Kahn T, Lyons NJ, Gough M, et al. 2022. CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy. Theranostics.
2021
Bajracharya R, Brici D, Bodea LD, et al. 2021. Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice. Acta Neuropathol Commun.
Chandler PG, Tan LL, Porebski B, et al. 2021. Mutational and biophysical robustness in a prestabilized monobody. The Journal of Biological Chemistry.
Chappell KJ, Mordant FL, Li Z, Wijesundara DK, et al. 2021. First Report of a Phase 1 Randomised Trial of Molecular Clamp-Stabilised Spike Protein-Based and MF59-Adjuvanted Vaccine for SARS-CoV-2.. The Lancet.
Chappell KJ, Mordant FL, Li Z, et al. 2021. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Infectious Disease.
Fercher C, Jones M, Mahler S, et al. 2021. Recombinant Antibody Engineering Enables Reversible Binding for Continuous Protein Biosensing. ACS Sensors.
Li J, Wuethrich A, Edwardraja S, et al. 2021. Amplification-Free SARS-CoV-2 Detection Using Nanoyeast-scFv and Ultrasensitive Plasmonic Nanobox-Integrated Nanomixing Microassay. Analytical Chemistry.
Macdonald MA, Nobel M, Roche Recinos D, et al. Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications. Critical Reviews in Biotechnology.
Watterson D, Wijesundara DK, Modhiran N, et al. 2021. Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Clinical & Translational Immunology. 10(4)
2020
Henry MN, MacDonald MA, Orellana CA, Gray PP, Gillard M, Baker K, Nielsen LK, Marcellin E, Mahler S, Martinez VS. 2020. Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production. Biotechnology and Bioengineering. 117(4)
McGowan EC, Flower RL, Jones ML, et al. 2020. Aggregates in blood filter chambers used from the plasma donations of anti-D donors: evaluation for monoclonal antibody discovery using phage display. Immunohaematology.
Orellana CA, Martinez VS, MacDonald MA, et al. 2020. ‘Omics driven discoveries of gene targets for apoptosis attenuation in CHO cells. Biotechnology Bioengineering.
Playford EG, Munro T, Mahler SM, et al. 2020. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. The Lancet Infectious Diseases. 4(20)
Roberts PJ, Kumarasamy V, Witkiewicz AK, et al. 2020. Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows. Molecular Cancer Therapeutics. 19(8)
Sun B, Gillard M, Wu Y, Wu P, Xu ZP, Gu W. 2020. Bisphosphonate Stabilized Calcium Phosphate Nanoparticles for Effective Delivery of Plasmid DNA to Macrophages. ACS Applied Bio Material. 3(2)
2019
Alfaleh MA, Arora N, Yeh M, de Bakker CJ, et al. 2019. Canine CD117-Specific Antibodies with Diverse Binding Properties Isolated from a Phage Display Library Using Cell-Based Biopanning. Antibodies. 8(1)
Findeisen M, Allen TL, Henstridge DC, et al.. 2019. Treatment of type 2 diabetes with the designer cytokine IC7Fc. Nature. 574
Greenall SA, McKenzie M, Seminova E, et al.. 2019. Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma. Neuro-Oncology. 21(8)
Harkness L, Chen X, Gillard M, Gray PP, Davies AM. 2019. Media composition modulates human embryonic stem cell morphology and may influence preferential lineage differentiation potential. PLoS ONE. 14(3)
Islam J, Riley BT, Fercher C, Jones ML, Buckle AM, Howard CB, Cox RP, Bell TDM, Mahler S, Corrie SR. 2019. Wavelength-Dependent Fluorescent Immunosensors via Incorporation of Polarity Indicators near the Binding Interface of Antibody Fragments. Analytical Chemistry. 91(12)
Jones ML. 2019. Use of bacteriophage for discovery of therapeutically relevant antibodies against infectious diseases. Microbiology Australia. 40(1)
Lee MD, Tong WY, Nebl T, Pearce LA, Pham TM, Golbaz-Hagh A, Puttick S, Rose S, Adams TE, Williams CC. 2019. Dual Site-Specific Labeling of an Antibody Fragment through Sortase A and π-Clamp Conjugation. Bioconjugate Chemistry. 30(10)
Modhiran N, Gandhi NS, Wimmer N, Cheung S, Stacey K, Young PR, Ferro V, Watterson D. 2019. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545. Antiviral Research. 168
Raftery LJ, Howard CB, Grewal YS, et al. 2019. Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencing. Lab on a Chip. 19
Sabir AJ, Adams TE, O'Rourke D, Devlin JM, Noormohammadi AH. 2019. Investigation onto the correlation between systemic antibodies to surface glycoproteins of infectious laryngotracheitis virus (ILTV) and protective immunity. Veterinary Microbiology. 228
Vaz PK, Hartley CA, Lee SY, et al. 2019. Koala and Wombat Gammaherpesviruses Encode the First Known Viral NTPDase Homologs and Are Phylogenetically Divergent from All Known Gammaherpesviruses. Journal of Virology. 93(6)
Walton KL, Chen JL, Arnold Q, Kelly E, La M, Lu L, Lovrecz G, Hagg A, Colgan TD, et al.. 2019. Activin A–Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male Mice. Endocrinology. 160(10)
Wang H, Kjer-Nielsen L, Shi M, et al. 2019. IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection. Science Immunology 4(41)
2018
Fontaine FR, Goodall S, Prokop JW, et al. 2018. Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach. mAbs. 10(4)
Staudacher AH, Li Y, Liapis V, Cheng Hou JJ, Chin D, Dolezal O, Adams TE, van Berkel PH, Brown MP. 2018. APOMAB Antibody–Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo. Large Molecule Therapeutics. 18(2)
Wong KY, Baron R, Seldon TA, Jones ML, Rice AM, Munster DJ. 2018. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell–Mediated CD4 T Cell Responses. The Journal of Immunology. 200(10)
2017
Alfaleh MA, Howard CB, Sedliarou I, et al. 2017. Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models. PLoS ONE. 12(10)
Lebani K, Jones ML, Watterson D, Ranzoni A, Traves RJ, Young PR, Mahler SM. 2017. Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay. PLoS ONE. 12(7)